Comments on "Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification".
Woo
Sook-Bin
SB
Mawardi
Hani
H
Treister
Nathaniel
N
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced / Q000145:classification*; D010020:Osteonecrosis / Q000139:chemically induced / Q000145:classification*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates